Global TCR-T Therapy Market Insights and Forecast to 2028
Table of Contents1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global TCR-T Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Autologous
1.2.3 Allogeneic
1.3 Market by Application
1.3.1 Global TCR-T Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Refractory Relapsed Melanoma
1.3.3 Synovial Sarcoma
1.3.4 Multiple Myeloma
1.3.5 Lung Cancer
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global TCR-T Therapy Market Perspective (2017-2028)
2.2 TCR-T Therapy Growth Trends by Region
2.2.1 TCR-T Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 TCR-T Therapy Historic Market Size by Region (2017-2022)
2.2.3 TCR-T Therapy Forecasted Market Size by Region (2023-2028)
2.3 TCR-T Therapy Market Dynamics
2.3.1 TCR-T Therapy Industry Trends
2.3.2 TCR-T Therapy Market Drivers
2.3.3 TCR-T Therapy Market Challenges
2.3.4 TCR-T Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top TCR-T Therapy Players by Revenue
3.1.1 Global Top TCR-T Therapy Players by Revenue (2017-2022)
3.1.2 Global TCR-T Therapy Revenue Market Share by Players (2017-2022)
3.2 Global TCR-T Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by TCR-T Therapy Revenue
3.4 Global TCR-T Therapy Market Concentration Ratio
3.4.1 Global TCR-T Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by TCR-T Therapy Revenue in 2021
3.5 TCR-T Therapy Key Players Head office and Area Served
3.6 Key Players TCR-T Therapy Product Solution and Service
3.7 Date of Enter into TCR-T Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 TCR-T Therapy Breakdown Data by Type
4.1 Global TCR-T Therapy Historic Market Size by Type (2017-2022)
4.2 Global TCR-T Therapy Forecasted Market Size by Type (2023-2028)
5 TCR-T Therapy Breakdown Data by Application
5.1 Global TCR-T Therapy Historic Market Size by Application (2017-2022)
5.2 Global TCR-T Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America TCR-T Therapy Market Size (2017-2028)
6.2 North America TCR-T Therapy Market Size by Type
6.2.1 North America TCR-T Therapy Market Size by Type (2017-2022)
6.2.2 North America TCR-T Therapy Market Size by Type (2023-2028)
6.2.3 North America TCR-T Therapy Market Share by Type (2017-2028)
6.3 North America TCR-T Therapy Market Size by Application
6.3.1 North America TCR-T Therapy Market Size by Application (2017-2022)
6.3.2 North America TCR-T Therapy Market Size by Application (2023-2028)
6.3.3 North America TCR-T Therapy Market Share by Application (2017-2028)
6.4 North America TCR-T Therapy Market Size by Country
6.4.1 North America TCR-T Therapy Market Size by Country (2017-2022)
6.4.2 North America TCR-T Therapy Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe TCR-T Therapy Market Size (2017-2028)
7.2 Europe TCR-T Therapy Market Size by Type
7.2.1 Europe TCR-T Therapy Market Size by Type (2017-2022)
7.2.2 Europe TCR-T Therapy Market Size by Type (2023-2028)
7.2.3 Europe TCR-T Therapy Market Share by Type (2017-2028)
7.3 Europe TCR-T Therapy Market Size by Application
7.3.1 Europe TCR-T Therapy Market Size by Application (2017-2022)
7.3.2 Europe TCR-T Therapy Market Size by Application (2023-2028)
7.3.3 Europe TCR-T Therapy Market Share by Application (2017-2028)
7.4 Europe TCR-T Therapy Market Size by Country
7.4.1 Europe TCR-T Therapy Market Size by Country (2017-2022)
7.4.2 Europe TCR-T Therapy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific TCR-T Therapy Market Size (2017-2028)
8.2 Asia-Pacific TCR-T Therapy Market Size by Type
8.2.1 Asia-Pacific TCR-T Therapy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific TCR-T Therapy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific TCR-T Therapy Market Share by Type (2017-2028)
8.3 Asia-Pacific TCR-T Therapy Market Size by Application
8.3.1 Asia-Pacific TCR-T Therapy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific TCR-T Therapy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific TCR-T Therapy Market Share by Application (2017-2028)
8.4 Asia-Pacific TCR-T Therapy Market Size by Region
8.4.1 Asia-Pacific TCR-T Therapy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific TCR-T Therapy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America TCR-T Therapy Market Size (2017-2028)
9.2 Latin America TCR-T Therapy Market Size by Type
9.2.1 Latin America TCR-T Therapy Market Size by Type (2017-2022)
9.2.2 Latin America TCR-T Therapy Market Size by Type (2023-2028)
9.2.3 Latin America TCR-T Therapy Market Share by Type (2017-2028)
9.3 Latin America TCR-T Therapy Market Size by Application
9.3.1 Latin America TCR-T Therapy Market Size by Application (2017-2022)
9.3.2 Latin America TCR-T Therapy Market Size by Application (2023-2028)
9.3.3 Latin America TCR-T Therapy Market Share by Application (2017-2028)
9.4 Latin America TCR-T Therapy Market Size by Country
9.4.1 Latin America TCR-T Therapy Market Size by Country (2017-2022)
9.4.2 Latin America TCR-T Therapy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa TCR-T Therapy Market Size (2017-2028)
10.2 Middle East & Africa TCR-T Therapy Market Size by Type
10.2.1 Middle East & Africa TCR-T Therapy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa TCR-T Therapy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa TCR-T Therapy Market Share by Type (2017-2028)
10.3 Middle East & Africa TCR-T Therapy Market Size by Application
10.3.1 Middle East & Africa TCR-T Therapy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa TCR-T Therapy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa TCR-T Therapy Market Share by Application (2017-2028)
10.4 Middle East & Africa TCR-T Therapy Market Size by Country
10.4.1 Middle East & Africa TCR-T Therapy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa TCR-T Therapy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Athenex
11.1.1 Athenex Company Details
11.1.2 Athenex Business Overview
11.1.3 Athenex TCR-T Therapy Introduction
11.1.4 Athenex Revenue in TCR-T Therapy Business (2017-2022)
11.1.5 Athenex Recent Developments
11.2 Xiangxue Pharmaceutical (Xiangxue Precision)
11.2.1 Xiangxue Pharmaceutical (Xiangxue Precision) Company Details
11.2.2 Xiangxue Pharmaceutical (Xiangxue Precision) Business Overview
11.2.3 Xiangxue Pharmaceutical (Xiangxue Precision) TCR-T Therapy Introduction
11.2.4 Xiangxue Pharmaceutical (Xiangxue Precision) Revenue in TCR-T Therapy Business (2017-2022)
11.2.5 Xiangxue Pharmaceutical (Xiangxue Precision) Recent Developments
11.3 Hengrui Yuanzheng
11.3.1 Hengrui Yuanzheng Company Details
11.3.2 Hengrui Yuanzheng Business Overview
11.3.3 Hengrui Yuanzheng TCR-T Therapy Introduction
11.3.4 Hengrui Yuanzheng Revenue in TCR-T Therapy Business (2017-2022)
11.3.5 Hengrui Yuanzheng Recent Developments
11.4 Eureka Therapeutics
11.4.1 Eureka Therapeutics Company Details
11.4.2 Eureka Therapeutics Business Overview
11.4.3 Eureka Therapeutics TCR-T Therapy Introduction
11.4.4 Eureka Therapeutics Revenue in TCR-T Therapy Business (2017-2022)
11.4.5 Eureka Therapeutics Recent Developments
11.5 WuXi Juno
11.5.1 WuXi Juno Company Details
11.5.2 WuXi Juno Business Overview
11.5.3 WuXi Juno TCR-T Therapy Introduction
11.5.4 WuXi Juno Revenue in TCR-T Therapy Business (2017-2022)
11.5.5 WuXi Juno Recent Developments
11.6 Shenzhen Inno Immunity
11.6.1 Shenzhen Inno Immunity Company Details
11.6.2 Shenzhen Inno Immunity Business Overview
11.6.3 Shenzhen Inno Immunity TCR-T Therapy Introduction
11.6.4 Shenzhen Inno Immunity Revenue in TCR-T Therapy Business (2017-2022)
11.6.5 Shenzhen Inno Immunity Recent Developments
11.7 Shenzhen Binde Bio
11.7.1 Shenzhen Binde Bio Company Details
11.7.2 Shenzhen Binde Bio Business Overview
11.7.3 Shenzhen Binde Bio TCR-T Therapy Introduction
11.7.4 Shenzhen Binde Bio Revenue in TCR-T Therapy Business (2017-2022)
11.7.5 Shenzhen Binde Bio Recent Developments
11.8 Kerui Bio
11.8.1 Kerui Bio Company Details
11.8.2 Kerui Bio Business Overview
11.8.3 Kerui Bio TCR-T Therapy Introduction
11.8.4 Kerui Bio Revenue in TCR-T Therapy Business (2017-2022)
11.8.5 Kerui Bio Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of TablesTable 1. Global TCR-T Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Autologous
Table 3. Key Players of Allogeneic
Table 4. Global TCR-T Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global TCR-T Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global TCR-T Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global TCR-T Therapy Market Share by Region (2017-2022)
Table 8. Global TCR-T Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global TCR-T Therapy Market Share by Region (2023-2028)
Table 10. TCR-T Therapy Market Trends
Table 11. TCR-T Therapy Market Drivers
Table 12. TCR-T Therapy Market Challenges
Table 13. TCR-T Therapy Market Restraints
Table 14. Global TCR-T Therapy Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global TCR-T Therapy Revenue Share by Players (2017-2022)
Table 16. Global Top TCR-T Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TCR-T Therapy as of 2021)
Table 17. Ranking of Global Top TCR-T Therapy Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by TCR-T Therapy Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players TCR-T Therapy Product Solution and Service
Table 21. Date of Enter into TCR-T Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global TCR-T Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global TCR-T Therapy Revenue Market Share by Type (2017-2022)
Table 25. Global TCR-T Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global TCR-T Therapy Revenue Market Share by Type (2023-2028)
Table 27. Global TCR-T Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global TCR-T Therapy Revenue Share by Application (2017-2022)
Table 29. Global TCR-T Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global TCR-T Therapy Revenue Share by Application (2023-2028)
Table 31. North America TCR-T Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America TCR-T Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America TCR-T Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America TCR-T Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America TCR-T Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America TCR-T Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe TCR-T Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe TCR-T Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe TCR-T Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe TCR-T Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe TCR-T Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe TCR-T Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific TCR-T Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific TCR-T Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific TCR-T Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific TCR-T Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific TCR-T Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific TCR-T Therapy Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America TCR-T Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America TCR-T Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America TCR-T Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America TCR-T Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America TCR-T Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America TCR-T Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa TCR-T Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa TCR-T Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa TCR-T Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa TCR-T Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa TCR-T Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa TCR-T Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 61. Athenex Company Details
Table 62. Athenex Business Overview
Table 63. Athenex TCR-T Therapy Product
Table 64. Athenex Revenue in TCR-T Therapy Business (2017-2022) & (US$ Million)
Table 65. Athenex Recent Developments
Table 66. Xiangxue Pharmaceutical (Xiangxue Precision) Company Details
Table 67. Xiangxue Pharmaceutical (Xiangxue Precision) Business Overview
Table 68. Xiangxue Pharmaceutical (Xiangxue Precision) TCR-T Therapy Product
Table 69. Xiangxue Pharmaceutical (Xiangxue Precision) Revenue in TCR-T Therapy Business (2017-2022) & (US$ Million)
Table 70. Xiangxue Pharmaceutical (Xiangxue Precision) Recent Developments
Table 71. Hengrui Yuanzheng Company Details
Table 72. Hengrui Yuanzheng Business Overview
Table 73. Hengrui Yuanzheng TCR-T Therapy Product
Table 74. Hengrui Yuanzheng Revenue in TCR-T Therapy Business (2017-2022) & (US$ Million)
Table 75. Hengrui Yuanzheng Recent Developments
Table 76. Eureka Therapeutics Company Details
Table 77. Eureka Therapeutics Business Overview
Table 78. Eureka Therapeutics TCR-T Therapy Product
Table 79. Eureka Therapeutics Revenue in TCR-T Therapy Business (2017-2022) & (US$ Million)
Table 80. Eureka Therapeutics Recent Developments
Table 81. WuXi Juno Company Details
Table 82. WuXi Juno Business Overview
Table 83. WuXi Juno TCR-T Therapy Product
Table 84. WuXi Juno Revenue in TCR-T Therapy Business (2017-2022) & (US$ Million)
Table 85. WuXi Juno Recent Developments
Table 86. Shenzhen Inno Immunity Company Details
Table 87. Shenzhen Inno Immunity Business Overview
Table 88. Shenzhen Inno Immunity TCR-T Therapy Product
Table 89. Shenzhen Inno Immunity Revenue in TCR-T Therapy Business (2017-2022) & (US$ Million)
Table 90. Shenzhen Inno Immunity Recent Developments
Table 91. Shenzhen Binde Bio Company Details
Table 92. Shenzhen Binde Bio Business Overview
Table 93. Shenzhen Binde Bio TCR-T Therapy Product
Table 94. Shenzhen Binde Bio Revenue in TCR-T Therapy Business (2017-2022) & (US$ Million)
Table 95. Shenzhen Binde Bio Recent Developments
Table 96. Kerui Bio Company Details
Table 97. Kerui Bio Business Overview
Table 98. Kerui Bio TCR-T Therapy Product
Table 99. Kerui Bio Revenue in TCR-T Therapy Business (2017-2022) & (US$ Million)
Table 100. Kerui Bio Recent Developments
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of FiguresFigure 1. Global TCR-T Therapy Market Share by Type: 2021 VS 2028
Figure 2. Autologous Features
Figure 3. Allogeneic Features
Figure 4. Global TCR-T Therapy Market Share by Application: 2021 VS 2028
Figure 5. Refractory Relapsed Melanoma Case Studies
Figure 6. Synovial Sarcoma Case Studies
Figure 7. Multiple Myeloma Case Studies
Figure 8. Lung Cancer Case Studies
Figure 9. Other Case Studies
Figure 10. TCR-T Therapy Report Years Considered
Figure 11. Global TCR-T Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global TCR-T Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global TCR-T Therapy Market Share by Region: 2021 VS 2028
Figure 14. Global TCR-T Therapy Market Share by Players in 2021
Figure 15. Global Top TCR-T Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TCR-T Therapy as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by TCR-T Therapy Revenue in 2021
Figure 17. North America TCR-T Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America TCR-T Therapy Market Size Market Share by Type (2017-2028)
Figure 19. North America TCR-T Therapy Market Size Market Share by Application (2017-2028)
Figure 20. North America TCR-T Therapy Market Size Share by Country (2017-2028)
Figure 21. United States TCR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada TCR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe TCR-T Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe TCR-T Therapy Market Size Market Share by Type (2017-2028)
Figure 25. Europe TCR-T Therapy Market Size Market Share by Application (2017-2028)
Figure 26. Europe TCR-T Therapy Market Size Share by Country (2017-2028)
Figure 27. Germany TCR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France TCR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. TCR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy TCR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia TCR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries TCR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific TCR-T Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific TCR-T Therapy Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific TCR-T Therapy Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific TCR-T Therapy Market Size Share by Region (2017-2028)
Figure 37. China TCR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan TCR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea TCR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia TCR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India TCR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia TCR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
List of FiguresFigure 43. Latin America TCR-T Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America TCR-T Therapy Market Size Market Share by Type (2017-2028)
Figure 45. Latin America TCR-T Therapy Market Size Market Share by Application (2017-2028)
Figure 46. Latin America TCR-T Therapy Market Size Share by Country (2017-2028)
Figure 47. Mexico TCR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil TCR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa TCR-T Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa TCR-T Therapy Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa TCR-T Therapy Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa TCR-T Therapy Market Size Share by Country (2017-2028)
Figure 53. Turkey TCR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia TCR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE TCR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Athenex Revenue Growth Rate in TCR-T Therapy Business (2017-2022)
Figure 57. Xiangxue Pharmaceutical (Xiangxue Precision) Revenue Growth Rate in TCR-T Therapy Business (2017-2022)
Figure 58. Hengrui Yuanzheng Revenue Growth Rate in TCR-T Therapy Business (2017-2022)
Figure 59. Eureka Therapeutics Revenue Growth Rate in TCR-T Therapy Business (2017-2022)
Figure 60. WuXi Juno Revenue Growth Rate in TCR-T Therapy Business (2017-2022)
Figure 61. Shenzhen Inno Immunity Revenue Growth Rate in TCR-T Therapy Business (2017-2022)
Figure 62. Shenzhen Binde Bio Revenue Growth Rate in TCR-T Therapy Business (2017-2022)
Figure 63. Kerui Bio Revenue Growth Rate in TCR-T Therapy Business (2017-2022)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed